11β-hydroxylase deficiency epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Epidemiology and Demographics== ===Prevalence=== ===Incidence=== CAH due to 11-beta-hydroxylase deficiency accounts f...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{}} | {{Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Revision as of 22:12, 25 January 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency epidemiology and demographics |
|
FDA on 11β-hydroxylase deficiency epidemiology and demographics |
|
CDC on 11β-hydroxylase deficiency epidemiology and demographics |
|
11β-hydroxylase deficiency epidemiology and demographics in the news |
|
Blogs on 11β-hydroxylase deficiency epidemiology and demographics |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
Incidence
CAH due to 11-beta-hydroxylase deficiency accounts for 5 to 8 percent of all cases of congenital adrenal hyperplasia. It is estimated that CAH due to 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns. This condition is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns